Clinical Research Directory

Inclusion Criteria: * 1\. \*\*Diagnosis of Pulmonary Fibrosis:\*\* * Patients must have a confirmed diagnosis of pulmonary fibrosis, as determined by clinical evaluation and imaging studies (e.g., high-resolution computed tomography). 2\. \*\*Age Range:\*\* * Participants should be adults aged 18 years and older to capture the adult population affected by the disease. 3\. \*\*Stable Clinical Condition:\*\* * Patients must be in a stable clinical condition, defined as no exacerbations or significant changes in treatment for at least four weeks prior to enrollmen Exclusion Criteria: * 1\. \*\*Other Significant Lung Diseases:\*\* * Patients with concurrent respiratory conditions (e.g., chronic obstructive pulmonary disease, asthma, or lung cancer) that could confound the results. 2\. \*\*Acute Exacerbations:\*\* * Individuals experiencing an acute exacerbation of pulmonary fibrosis or any significant respiratory illness within four weeks prior to enrollment. 3\. \*\*Severe Comorbidities:\*\* * Patients with severe cardiovascular disease, uncontrolled hypertension, major neurological disorders, or musculoskeletal problems that would impede participation in exercise. 4\. \*\*Cognitive Impairment:\*\* * Individuals with cognitive impairments that prevent them from understanding the study procedures or following the rehabilitation program.